Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical corticosteroids, corticosteroids under occlusion, and topical brimonidine to prevent postinflammatory hyperpigmentation after Q-switched 532-nm Nd:YAG laser for solar lentigines
TCTR20231024002Phase 3Completed
- Sponsor
- Faculty of Medicine, Srinakharinwirot University
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of corticosteroids, brimonidine in actinic lentigo, Post-inflammatory hyperpigmentation (PIH), sponsored by Faculty of Medicine, Srinakharinwirot University. Started Mar 2022; status: completed.
02
Drugs
corticosteroidsbrimonidine
03
Conditions
actinic lentigoPost-inflammatory hyperpigmentation (PIH)
Beyond the preview
Go deeper on TCTR20231024002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20231024002.